Company Details
|
|
Address
|
4 Eden Close, Hellaby Industrial Estate, Rotherham, S66 8RW
|
|
Telephone
|
01709 730 730
|
|
Fax
|
01709 730 000
|
Executives
|
|
Executive Chairman
|
Kevin Gilmore* (36.40% holding)
|
|
Managing Director
|
John Crispin (8.80% holding)
|
|
Finance Director
|
Mark Adamson (0.00% holding)
|
|
Director
|
Barry Dale (4.00% holding)
|
Main Shareholders
|
|
|
Gordon Arbib: 11% Barclays: 7.2% SVM Asset Management: 5.6% Mary Crispin: 3%
|
Advisers
|
|
Nominated Adviser
|
Beaumont Cornish
|
|
Nominated Broker
|
HB Corporate; Hoodless Brennan; Daniel Stewart
|
|
Solicitors
|
BPE
|
|
Auditors
|
Baker Tilly
|
|
Registrar
|
Neville Registrars
|
|
Commentary
|
|
Medical devices company which designs, manufactures, sells and services healthcare decontamination equipment
|
Company Data |
| Code |
DSY |
| Sedol |
GB00300328 |
| Shares In Issue |
20.613 m |
| Indices
|
Aim |
| Entry on AIM |
14/10/2002 |
| Interim Results |
Jun |
| Final Results |
Mar |
| Year End |
Sep |
| Accounts Due |
Mar |
| Int div payment |
n/a |
| Fin div payment |
n/a |
| Int net div per share |
nil |
| Fin net div per share |
nil |
| Probable CGT relief |
Yes |
| |
|
|